MILESTONE PHARMACEUTICALS IN (MIST)

CA59935V1076 - Common Stock

1.88  +0.08 (+4.44%)

News Image
7 days ago - BusinessInsider

MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Milestone Pharmaceuticals (NASDAQ:MIST) just reported results for the fourth qu...

News Image
7 days ago - InvestorPlace

MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023

MIST stock results show that Milestone Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

News Image
7 days ago - Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

- On track to resubmit NDA for etripamil in PSVT early 2Q 2024 - Recent financing extends cash runway into 2026 - FDA reiterated prior guidance on...

News Image
a month ago - Milestone Pharmaceuticals Inc.

Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference

MONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

News Image
a month ago - Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants

MONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical...

News Image
a month ago - Seeking Alpha

Milestone Pharmaceuticals launches stock and warrants offering (NASDAQ:MIST)

Milestone Pharmaceuticals (NASDAQ:MIST) said Wednesday it has commenced an underwritten public offering of its common shares and pre-funded warrants to...

News Image
a month ago - Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical...

News Image
a month ago - Seeking Alpha

Milestone rallies 23% on FDA update for tachycardia drug (NASDAQ:MIST)

Milestone Pharmaceuticals (MIST) stock shot up 23% Monday after the company said it plans to resubmit the New Drug Application for its drug etripamil in Q2 2024. Read more here.

News Image
2 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. ("Milestone" or the "Company") (NASDAQ: MIST)....

News Image
2 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. ("Milestone" or the "Company") (NASDAQ: MIST)....

News Image
3 months ago - THE ROSEN LAW FIRM, P. A.

ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...

News Image
3 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. ("Milestone" or the "Company") (NASDAQ: MIST)....

News Image
3 months ago - NewMediaWire

ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Image
3 months ago - NewMediaWire

ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Image
3 months ago - THE ROSEN LAW FIRM, P. A.

ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST

/PRNewswire/ -- WHY: New York, N.Y., December 30, 2023. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities...

News Image
3 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. ("Milestone" or the "Company") (NASDAQ: MIST)....

News Image
3 months ago - Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT

MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company received...

News Image
4 months ago - Milestone Pharmaceuticals, Inc.

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

/CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in a fireside chat at the Piper...

News Image
4 months ago - Milestone Pharmaceuticals, Inc.

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in a fireside chat at the...